前沿生物: 前沿生物2024年年度股东大会决议公告

Meeting Overview - The shareholders' meeting of Frontier Biopharmaceuticals (Nanjing) Co., Ltd. was held on May 23, 2025, at the Nanjing Jiayue Yinh Lake Hotel [1] - A total of 93 ordinary shareholders attended the meeting, holding 173,180,166 voting rights, which represents 46.2333% of the company's total voting rights [1] Voting Results - All non-cumulative voting proposals were approved with significant majority support, including: - Proposal 1: 171,966,908 votes in favor (99.2994%) [1] - Proposal 2: 171,966,908 votes in favor (99.2994%) [1] - Proposal 3: 171,858,906 votes in favor (99.2370%) [1] - Proposal 4: 171,592,074 votes in favor (99.0829%) [1] - The voting results indicate a strong consensus among shareholders for the proposed resolutions [2][3] Legal Compliance - The meeting was conducted in accordance with legal and regulatory requirements, as confirmed by the attending lawyers [3]